¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Behavioral Risk Factor Surveillance System"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
behavioral risk factor
ÇൿÀ§Çè¿äÀÎ
risk factor
À§ÇèÀÎÀÚ
behavioral genetics
ÇൿÀ¯ÀüÇÐ
behavioral modification
Çൿ¼öÁ¤
behavioral observation audiometry
Çൿ°üÂûû·Â°Ë»ç
behavioral science
Çൿ°úÇÐ
behavioral therapy
Çൿ¿ä¹ý
epidemiological surveillance
¿ªÇа¨½Ã
immune surveillance
¸é¿ª°¨½Ã
immunological surveillance
¸é¿ª°¨½Ã
infection control surveillance
°¨¿°°ü¸®°¨½Ã
post-marketing surveillance
½ÃÆÇÈĺÎÀÛ¿ë°¨½Ã
surveillance
°¨½Ã, °¨µ¶
attributable risk
±âÀÎÀ§Çèµµ
absolute risk model
Àý´ëÀ§Çè¸ðÇü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
risk factor
À§ÇèÀÎÀÚ
surveillance
°¨½Ã
behavioral modification
Çൿ¼öÁ¤
behavioral therapy
Çൿ¿ä¹ý
high risk group
°íÀ§Ç豺
low risk group
ÀúÀ§Ç豺
risk
À§Çè, À§Çèµµ
attributable risk
±â¿©À§Çèµµ
relative risk
ºñ±³À§Çèµµ
surgical risk
¼ö¼úÀ§Çèµµ
system analysis
°èÅëºÐ¼®
system
1.°è, °èÅë, ü°è, 2.ÀåÄ¡, 3.Á¦µµ,
Bethesta system
º£Å×½ºÅ¸ºÐ·ù(¹ý)
biliary system
´ãµµ°è, ¾µ°³°èÅë
blood group system
Ç÷¾×Çü±º
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
behavioral risk factor
ÇൿÀ§Çè¿äÀÎ
risk factor
À§ÇèÀÎÀÚ
behavioral observation audiometry
Çൿ°üÂûû·Â°Ë»ç
behavioral epidemic
ÇൿÀ¯Çà
behavioral genetics
ÇൿÀ¯ÀüÇÐ
behavioral modification
Çൿ¼öÁ¤
behavioral therapy
Çൿ¿ä¹ý
postencephalitic behavioral syndrome
³ú¿°ÈÄÇൿÁõÈıº
surveillance data
°ü¸®Á¤º¸Á¶»çÀÚ·á
epidemiological surveillance
¿ªÇа¨½Ã,
immune surveillance
¸é¿ª°¨½Ã
immunological surveillance
¸é¿ª°¨½Ã
infection control surveillance
°¨¿°°ü¸®°¨½Ã
post-marketing surveillance
½ÃÆÇÈĺÎÀÛ¿ëÁ¶»ç
surveillance
°¨½Ã
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
postencephalitic behavioral syndrome
³ú¿°ÈÄ ÇൿÁõÈıº
PMS : post marketing surveillance
½ÃÆÇÈÄ ºÎÀÛ¿ëÁ¶»ç.
immune surveillance
¸é¿ª°¨½Ã
immune surveillance
¸é¿ª[ÇÐÀû]°¨½Ã±âÀü
immunologic surveillance
¸é¿ª°¨½Ã(±â±¸).
immunological surveillance
¸é¿ª°¨½Ã(±â±¸)(ÊÙ˧Ëà˻˴), ¸é¿ªÁ¶»ç.
immunological surveillance
¸é¿ª°¨½Ã(±â±¸)(¡ÊøãÊѦϰ), ¸é¿ªÁ¶»ç.
infection control surveillance
°¨¿°°ü¸®°¨½Ã
post marketing surveillance
½ÃÆÇÈÄ ºÎÀÛ¿ëÁ¶»ç
T-tubular system =>transverse tubular system
T-°è, °¡·Î¼Ò°ü °èÅë
absolute risk
Àý´ëÀ§Çè
absolute risk model
Àý´ëÀ§Çè¸ðµ¨
acceptable risk
¿ëÀÎÀ§Çèµµ, ¼ö¿ëÀ§Çèµµ
anesthetic risk
¸¶ÃëÀ§Çèµµ.
high risk group
°íÀ§Çèµµ±º(ËËô̴̬˴).
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
coronary risk factor
°ü(»ó)(µ¿¸Æ)ÁúȯÀ§Çè¿äÀÎ.
risk factor
À§ÇèÀÎÀÚ
epidemiological surveillance
¿ªÇÐÀû °¨½Ã(ËçÌ°ËøË§Ëà), ¿ªÇÐÀû °ü¸®Á¤º¸Á¶ »ç.
immune surveillance
¸é¿ª[ÇÐÀû]°¨½Ã±âÀü
immune surveillance
¸é¿ª°¨½Ã
immunologic surveillance
¸é¿ª°¨½Ã(±â±¸).
immunological surveillance
¸é¿ª°¨½Ã(±â±¸)(¡ÊøãÊѦϰ), ¸é¿ªÁ¶»ç.
immunological surveillance
¸é¿ª°¨½Ã(±â±¸)(ÊÙ˧Ëà˻˴), ¸é¿ªÁ¶»ç.
infection control surveillance
°¨¿°°ü¸®°¨½Ã
post marketing surveillance
½ÃÆÇÈÄ ºÎÀÛ¿ëÁ¶»ç
surveillance
°ü¸®Á¤º¸Á¶»ç(Ë´ËöËøËÓÌ¡Ë×), °¨½Ã±â±¸(˧Ëà˻˴).
surveillance data
°ü¸®Á¤º¸Á¶»çÀÚ·á
audiometry, behavioral observation
Çൿ°üÂûû·Â°Ë»ç
behavioral - cognitive therapy
Çൿ(ÇàÅÂ)ÀÎÁöÀû Ä¡·á
behavioral abnormality =b. disorder
ÇൿÀÌ»ó(ú¼ÔÑì¶ßÈ)=ÇൿÀå¾Ö
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½